You are here

  • Home
  • Archive
  • Volume 11, Issue 4
  • Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases

 

Online download statistics by month:

Online download statistics by month: April 2023 to January 2026

AbstractFullPdf
Apr 2023989994246
May 202346947897
Jun 202321722075
Jul 202318618788
Aug 202331932262
Sep 202313213443
Oct 202313914246
Nov 202324424741
Dec 202318218747
Jan 202410210257
Feb 202414514839
Mar 2024172175101
Apr 202415617282
May 202412112654
Jun 202410510443
Jul 202416917352
Aug 2024949280
Sep 2024858941
Oct 2024121132181
Nov 202412612942
Dec 202411211640
Jan 2025838442
Feb 202518318428
Mar 202510811349
Apr 202514214354
May 202513113267
Jun 2025616137
Jul 2025110
Aug 2025110
Jan 2026110
Total509651891834